Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis

Table 2 The proportion of Child-Pugh class B patients at baseline in studies

Study	BCAA		Control		Total
Nishikawa et al. 2013	30/115	26 %	52/141	37 %	82/256	32 %	**
Kanekawa et al. 2014	26/49	53 %	13/43	30 %	39/92	42 %	**
Takeda et al. 2014	18/33	55 %	14/44	32 %	32/77	42 %	**
Kuroda et al. 2010	11/20	55 %	8/15	53 %	19/35	54 %	**
Nagasue et al. 1998	13/67	19 %	14/65	22 %	27/132	20 %	*
Meng et al. 1999	4/21	19 %	3/24	13 %	7/45	16 %	*
Ichikawa et al. 2013	5/26	19 %	5/30	17 %	10/56	18 %	*
Okabayashi et al. 2008	7/40	18 %	10/72	14 %	17/112	15 %	*

**: Study that reported significantly lower mortality in the BCAA group compared with the control group
*: Study that reported no significant difference in mortality between the two groups

ISSN: 1475-2891